NCT00002546已完成3 期
A Phase III Randomized Study of Accelerated Hyperfractionated Whole Abdominal Radiotherapy (AHWAR) Versus Combination Ifosfamide-Mesna With Cisplatin in Optimally Debulked Stage I, II, III, or IV Carcinosarcoma (CS) of The Uterus
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 216
- 试验地点
- 65
研究概览
简要总结
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy is more effective than combination chemotherapy in treating patients with cancer of the uterus.
PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared to combination chemotherapy in treating patients with cancer of the uterus.
详细描述
OBJECTIVES:
- Compare the survival, progression-free interval, and failure patterns in patients with optimally debulked stage I-IV carcinosarcoma of the uterus treated with whole abdominal radiotherapy vs ifosfamide and cisplatin.
- Compare the incidence and type of acute and late adverse events observed with these treatment regimens in this patient population.
OUTLINE: This is a randomized, multicenter study. Patients are randomized to one of two treatment arms.
- Arm I: Patients receive whole abdominal radiotherapy 5 days a week for 4 weeks, followed by radiotherapy boost to the pelvis 5 days a week for 2.2 weeks.
- Arm II: Patients receive cisplatin IV followed by ifosfamide IV over 1 hour on days 1-4. Treatment continues every 3 weeks for 3 courses.
Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
入排标准
- 年龄范围
- 21 Years 至 120 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •DISEASE CHARACTERISTICS:
- •Histologically confirmed primary homologous or heterologous carcinosarcoma of the uterus (corpus and cervix)
- •Surgical stage I-IV disease, including positive adnexa, tumor invading the serosa, positive pelvic and/or para-aortic nodes, involvement of the mucosa of the bowel, bladder, or rectum, intra-abdominal metastases, positive pelvic washings, or vaginal involvement within planned radiation port
- •Prior total abdominal hysterectomy with bilateral salpingo-oophorectomy and maximum tumor resection of all gross intra-abdominal/pelvic disease, including grossly involved pelvic and para-aortic nodes within 8 weeks before study
- •No greater than 1 cm residual disease
- •Cervical sarcomas also allowed
- •No metastasis beyond the abdominal cavity at diagnosis, including the following:
- •Parenchymal liver metastasis
- •Lung metastasis
- •Positive inguinal lymph nodes
- •Positive scalene nodes
- •Radiographic or pathologic evidence of bone or brain metastasis
- •PATIENT CHARACTERISTICS:
- •21 and over
- •Performance status:
- •Hematopoietic:
- •WBC at least 3,000/mm3
- •Granulocyte count at least 1,500/mm3
- •Platelet count at least 100,000/mm3
- •Bilirubin no greater than 1.5 times normal
- •SGOT no greater than 3 times normal
- •Albumin at least 3 g/dL
- •No acute hepatitis
- •Creatinine no greater than 1.5 mg/dL OR
- •Creatinine clearance at least 50 mL/min
- •No septicemia
- •No severe infection
- •No severe gastrointestinal bleeding
- •No prior invasive or concurrent malignancy within the past 5 years except nonmelanoma skin cancer
- •PRIOR CONCURRENT THERAPY:
- •Biologic therapy:
- •Not specified
- •Chemotherapy:
- •No prior chemotherapy
- •Endocrine therapy:
- •Prior hormonal therapy allowed
- •Radiotherapy:
- •See Disease Characteristics
- •No prior radiotherapy
- •See Disease Characteristics
- •No prior therapy that would preclude study therapy
排除标准
- 未提供
研究者
研究点 (65)
Loading locations...
相似试验
已完成
3 期
Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck CancerHead and Neck CancerNCT00002654Swiss Cancer Institute224
已完成
3 期
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed GliomasBrain and Central Nervous System TumorsNCT00004259Radiation Therapy Oncology Group230
已完成
3 期
Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical CancerCervical CancerNCT00003209European Organisation for Research and Treatment of Cancer - EORTC700
已完成
1 期
Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung CancerLung CancerNCT00023673Radiation Therapy Oncology Group63
已完成
3 期
Radiation Therapy Plus Combination Chemotherapy in Treating Children With MedulloblastomaCentral Nervous System TumorsBrain TumorsNCT00002875Children's Oncology Group421